Peter Riskind to Follow-Up Studies
This is a "connection" page, showing publications Peter Riskind has written about Follow-Up Studies.
Connection Strength
0.046
-
van Rossum JA, Killestein J, Villar LM, Riskind PN, Freedman MS, Teunissen C. gMS-Classifier1 does not predict disability progression in multiple sclerosis. Mult Scler. 2019 06; 25(7):1010-1011.
Score: 0.026
-
Paradas C, Akman HO, Ionete C, Lau H, Riskind PN, Jones DE, Smith TW, Hirano M, Dimauro S. Branching enzyme deficiency: expanding the clinical spectrum. JAMA Neurol. 2014 Jan; 71(1):41-7.
Score: 0.019